HIGHLIGHTS
- who: Cécile Oury from the Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, University of, Heart Valve Clinic, Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy have published the paper: Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets, in the Journal: (JOURNAL)
- what: CAVD is a complex multi-step event that involves numerous biological processes from lipid accumulation, inflammation to osteogenesis.
- future: Recent advances and future directions bring hope for the development of efficient drug treatment and for the reduction of valve replacement surgeries . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.